Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly.
Te-Ling MaWei-Chen TaiSong-Seng LokeChih-Chien YaoChih-Ming LiangSeng-Kee ChuahPublished in: Drugs & aging (2023)
The efficacy of non-bismuth concomitant quadruple therapy in the elderly cohort was comparable with that in the non-elderly cohort for first-line H. pylori eradication with acceptable adverse effects.